SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10872566
Source:
http://linkedlifedata.com/resource/pubmed/id/10872566
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004147
,
umls-concept:C0030705
,
umls-concept:C0035173
,
umls-concept:C0126174
,
umls-concept:C0205409
,
umls-concept:C0221155
,
umls-concept:C0406582
,
umls-concept:C1257890
pubmed:issue
6
pubmed:dateCreated
2000-10-10
pubmed:abstractText
To compare the efficacy and tolerability of angiotensin II (Ang II) antagonist losartan and the beta-blocker atenolol in the treatment of patients with isolated systolic hypertension (ISH) after 16 weeks of treatment.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8306882
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II
,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Atenolol
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrochlorothiazide
,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0263-6352
pubmed:author
pubmed-author:ADAMH EHE
,
pubmed-author:BortmanGG
,
pubmed-author:FarsangCC
,
pubmed-author:Garcia-PuigJJ
,
pubmed-author:NiegowskaJJ
,
pubmed-author:VrijensFF
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
795-801
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10872566-Adrenergic beta-Antagonists
,
pubmed-meshheading:10872566-Aged
,
pubmed-meshheading:10872566-Angiotensin II
,
pubmed-meshheading:10872566-Antihypertensive Agents
,
pubmed-meshheading:10872566-Atenolol
,
pubmed-meshheading:10872566-Blood Pressure
,
pubmed-meshheading:10872566-Double-Blind Method
,
pubmed-meshheading:10872566-Drug Therapy, Combination
,
pubmed-meshheading:10872566-Female
,
pubmed-meshheading:10872566-Humans
,
pubmed-meshheading:10872566-Hydrochlorothiazide
,
pubmed-meshheading:10872566-Hypertension
,
pubmed-meshheading:10872566-Losartan
,
pubmed-meshheading:10872566-Male
,
pubmed-meshheading:10872566-Middle Aged
,
pubmed-meshheading:10872566-Systole
,
pubmed-meshheading:10872566-Treatment Outcome
pubmed:year
2000
pubmed:articleTitle
The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group.
pubmed:affiliation
Szent Imre Hospit, Budapest, Hungary. hunghyp@mail.matav.hu
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't